← All companies
S
Spyre Therapeutics, Inc.
SYRE - Company ID 0001636282
Market cap$7.73 B
Rank#1112
Filings762
Spyre Therapeutics, Inc. has filed 762 public company documents between 2015 and 2026. The most frequent type is insider trade (195 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Continue researchSYRE overview$7.73 BMarket cap, financials, charts, and latest company context.
Continue researchMarket cap historyRank #1112See the market value trend behind the filing history.
Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.
Continue researchCompare with LLYPeer viewPut SYRE beside LLY across market cap, revenue, income, and filings.
Similar companies to research next
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.